Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer

authors

  • Couderc Anne-Laure
  • Ninove Laetitia
  • Nouguerède Emilie
  • Rey Dominique
  • Rebroin Marina
  • Daumas Aurélie
  • Tomasini Pascale
  • Greillier Laurent
  • Salas Sebastien
  • Duffaud Florence
  • Dahan Laetitia
  • Duluc Muriel
  • Garcia Marie-Eve
  • Pluvy Johan
  • Chaléat Solène
  • Farnault Laure
  • Venton Geoffroy
  • Fourié Toscane
  • Nurtop Elif
  • de Lamballerie Xavier
  • Villani Patrick
  • Charrel Remi
  • Correard Florian

keywords

  • Immunotherapy
  • Lenvatinib
  • Pembrolizumab
  • Second-line
  • Thymic epithelial tumors
  • Aged
  • COVID-19
  • Drug-related side effects and adverse reactions
  • Geriatric assessment
  • Medical oncology
  • Vaccination

document type

ART

abstract

The COVID-19 vaccination campaign began in December 2020, in France, and primarily targeted the oldest people. Our study aimed to determine the level of acceptance of vaccination in a population of older patients with cancer.

more information